432 related articles for article (PubMed ID: 16230210)
21. Caspofungin in combination with amphotericin B against Candida glabrata.
Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
[TBL] [Abstract][Full Text] [Related]
22. Broviac catheter-related candidemia.
Castagnola E; Marazzi MG; Tacchella A; Giacchino R
Pediatr Infect Dis J; 2005 Aug; 24(8):747. PubMed ID: 16094241
[No Abstract] [Full Text] [Related]
23. Outcome of treatment of candidemia in children whose central catheters were removed or retained.
Eppes SC; Troutman JL; Gutman LT
Pediatr Infect Dis J; 1989 Feb; 8(2):99-104. PubMed ID: 2704608
[TBL] [Abstract][Full Text] [Related]
24. Cure of Candida glabrata native tricuspid valve endocarditis by continuous infusion of conventional amphotericin B in a patient with nephrotic syndrome.
Williams J; Lye DC
Int J Antimicrob Agents; 2007 Aug; 30(2):192-3. PubMed ID: 17555946
[No Abstract] [Full Text] [Related]
25. Candida glabrata fungaemia in intensive care units.
Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
[TBL] [Abstract][Full Text] [Related]
26. Non Candida albicans fungal peritonitis in continuous ambulatory peritoneal dialysis patients.
Kleinpeter MA; Butt AA
Adv Perit Dial; 2001; 17():176-9. PubMed ID: 11510270
[TBL] [Abstract][Full Text] [Related]
27. The treatment of candidemia.
Girmenia C; Martino P
N Engl J Med; 1995 Apr; 332(16):1101; author reply 1101-2. PubMed ID: 7898538
[No Abstract] [Full Text] [Related]
28. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
[TBL] [Abstract][Full Text] [Related]
29. Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome.
Mouw E; Chessman K; Lesher A; Tagge E
J Pediatr Surg; 2008 Jun; 43(6):1025-9. PubMed ID: 18558177
[TBL] [Abstract][Full Text] [Related]
30. Torulopsis glabrata fungemia from infected transjugular intrahepatic portosystemic shunt stent.
Brickey TW; Trotter JF; Johnson SP
J Vasc Interv Radiol; 2005 May; 16(5):751-2. PubMed ID: 15872333
[TBL] [Abstract][Full Text] [Related]
31. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
[TBL] [Abstract][Full Text] [Related]
32. [Candidemia: a never ceasing challenge].
Muñoz García de Paredes P
Rev Clin Esp; 1997 Dec; 197(12):795-7. PubMed ID: 9477668
[No Abstract] [Full Text] [Related]
33. Antifungal catheter lock therapy for the management of a persistent Candida albicans bloodstream infection in an adult receiving hemodialysis.
Paul DiMondi V; Townsend ML; Johnson M; Durkin M
Pharmacotherapy; 2014 Jul; 34(7):e120-7. PubMed ID: 24782326
[TBL] [Abstract][Full Text] [Related]
34. Candidemia: a nosocomial complication in adults with late-stage AIDS.
Launay O; Lortholary O; Bouges-Michel C; Jarrousse B; Bentata M; Guillevin L
Clin Infect Dis; 1998 May; 26(5):1134-41. PubMed ID: 9597242
[TBL] [Abstract][Full Text] [Related]
35. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
[TBL] [Abstract][Full Text] [Related]
36. In vitro effectiveness of antifungal lock solutions on catheters infected with Candida species.
Öncü S
J Infect Chemother; 2011 Oct; 17(5):634-9. PubMed ID: 21327934
[TBL] [Abstract][Full Text] [Related]
37. Breakthrough fungemia due to Candida glabrata during posaconazole prophylaxis in hematology patients treated with anidulafungin - report of 5 cases.
Krcmery V; Demitrovicova A; Kisac P
J Chemother; 2011 Oct; 23(5):310-1. PubMed ID: 22005067
[No Abstract] [Full Text] [Related]
38. Fluconazole plus amphotericin B combinations are not contraindicated and may add benefit for the treatment of candidemia.
Odds FC
Clin Infect Dis; 2003 May; 36(10):1229-31. PubMed ID: 12746766
[No Abstract] [Full Text] [Related]
39. Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome.
Atkinson BJ; Lewis RE; Kontoyiannis DP
Med Mycol; 2008 Sep; 46(6):541-6. PubMed ID: 19180749
[TBL] [Abstract][Full Text] [Related]
40. [Multicenter study of fungemia due to yeasts in Argentina].
Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A;
Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
